Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)
USD 25.04
(-1.14%)
USD 25.04
(-1.14%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 116.41 Million USD | 1372.89% |
| 2022 | 7.9 Million USD | -77.92% |
| 2021 | 35.78 Million USD | 84.18% |
| 2020 | 19.43 Million USD | 19.64% |
| 2019 | 16.24 Million USD | 88.64% |
| 2018 | 8.61 Million USD | -23.85% |
| 2017 | 11.3 Million USD | 133.95% |
| 2016 | 4.83 Million USD | -14.81% |
| 2015 | 5.67 Million USD | 169.45% |
| 2014 | -8.16 Million USD | 47.57% |
| 2013 | -15.57 Million USD | -55.24% |
| 2012 | -10.03 Million USD | -881.4% |
| 2011 | 1.28 Million USD | 68.1% |
| 2010 | 764.01 Thousand USD | 148.06% |
| 2009 | -1.58 Million USD | 68.9% |
| 2008 | -5.11 Million USD | -37.9% |
| 2007 | -3.7 Million USD | -9178.91% |
| 2006 | -39.94 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 123.12 Million USD | 5.76% |
| 2024 Q2 | 121.36 Million USD | -1.43% |
| 2023 Q2 | 146.95 Million USD | -1.77% |
| 2023 Q4 | 116.41 Million USD | -0.14% |
| 2023 Q3 | 116.57 Million USD | -20.67% |
| 2023 FY | 116.41 Million USD | 1372.89% |
| 2023 Q1 | 149.6 Million USD | 1792.74% |
| 2022 Q4 | 7.9 Million USD | -77.74% |
| 2022 Q3 | 35.5 Million USD | 4.6% |
| 2022 Q2 | 33.94 Million USD | -8.72% |
| 2022 FY | 7.9 Million USD | -77.92% |
| 2022 Q1 | 37.18 Million USD | 3.89% |
| 2021 FY | 35.78 Million USD | 84.18% |
| 2021 Q4 | 35.78 Million USD | 90.06% |
| 2021 Q1 | 14.46 Million USD | -25.55% |
| 2021 Q3 | 18.83 Million USD | 393.45% |
| 2021 Q2 | 3.81 Million USD | -73.62% |
| 2020 Q4 | 19.43 Million USD | 3.53% |
| 2020 Q2 | 20.35 Million USD | 19.0% |
| 2020 Q3 | 18.76 Million USD | -7.79% |
| 2020 Q1 | 17.1 Million USD | 5.31% |
| 2020 FY | 19.43 Million USD | 19.64% |
| 2019 Q4 | 16.24 Million USD | -3.44% |
| 2019 Q2 | 16.62 Million USD | -1.15% |
| 2019 Q1 | 16.81 Million USD | 95.32% |
| 2019 FY | 16.24 Million USD | 88.64% |
| 2019 Q3 | 16.82 Million USD | 1.19% |
| 2018 Q1 | 12.62 Million USD | 11.67% |
| 2018 Q4 | 8.61 Million USD | -3.96% |
| 2018 Q3 | 8.96 Million USD | -19.47% |
| 2018 Q2 | 11.13 Million USD | -11.82% |
| 2018 FY | 8.61 Million USD | -23.85% |
| 2017 FY | 11.3 Million USD | 133.95% |
| 2017 Q4 | 11.3 Million USD | -1.29% |
| 2017 Q3 | 11.45 Million USD | 23.88% |
| 2017 Q2 | 9.24 Million USD | 42.83% |
| 2017 Q1 | 6.47 Million USD | 33.95% |
| 2016 Q4 | 4.83 Million USD | -47.7% |
| 2016 FY | 4.83 Million USD | -14.81% |
| 2016 Q2 | 3.98 Million USD | 247.03% |
| 2016 Q3 | 9.24 Million USD | 132.19% |
| 2016 Q1 | -2.7 Million USD | -147.72% |
| 2015 Q3 | 1.68 Million USD | 186.39% |
| 2015 FY | 5.67 Million USD | 169.45% |
| 2015 Q1 | -2.85 Million USD | 65.0% |
| 2015 Q2 | -1.95 Million USD | 31.62% |
| 2015 Q4 | 5.67 Million USD | 235.88% |
| 2014 Q1 | -14.2 Million USD | 8.85% |
| 2014 Q4 | -8.16 Million USD | 20.81% |
| 2014 Q3 | -10.31 Million USD | 14.65% |
| 2014 Q2 | -12.08 Million USD | 14.9% |
| 2014 FY | -8.16 Million USD | 47.57% |
| 2013 Q1 | -19.02 Million USD | -89.61% |
| 2013 FY | -15.57 Million USD | -55.24% |
| 2013 Q4 | -15.57 Million USD | 7.42% |
| 2013 Q3 | -16.82 Million USD | 6.36% |
| 2013 Q2 | -17.97 Million USD | 5.56% |
| 2012 Q2 | -7.71 Million USD | -1769.51% |
| 2012 FY | -10.03 Million USD | -881.4% |
| 2012 Q4 | -10.03 Million USD | 8.69% |
| 2012 Q1 | 462.24 Thousand USD | -64.01% |
| 2012 Q3 | -10.99 Million USD | -42.42% |
| 2011 Q1 | 1 Million USD | 31.29% |
| 2011 FY | 1.28 Million USD | 68.1% |
| 2011 Q3 | 1.1 Million USD | 2.05% |
| 2011 Q2 | 1.08 Million USD | 8.38% |
| 2011 Q4 | 1.28 Million USD | 15.76% |
| 2010 FY | 764.01 Thousand USD | 148.06% |
| 2010 Q1 | -951.88 Thousand USD | 40.12% |
| 2010 Q2 | -1.04 Million USD | -9.53% |
| 2010 Q3 | -467.27 Thousand USD | 55.18% |
| 2010 Q4 | 764.01 Thousand USD | 263.5% |
| 2009 FY | -1.58 Million USD | 68.9% |
| 2009 Q4 | -1.58 Million USD | 20.48% |
| 2009 Q3 | -1.99 Million USD | 31.12% |
| 2009 Q2 | -2.9 Million USD | 30.79% |
| 2009 Q1 | -4.19 Million USD | 17.95% |
| 2008 Q3 | -5.77 Million USD | 13.93% |
| 2008 Q1 | -3.4 Million USD | 8.04% |
| 2008 Q4 | -5.11 Million USD | 11.51% |
| 2008 FY | -5.11 Million USD | -37.9% |
| 2008 Q2 | -6.71 Million USD | -96.89% |
| 2007 FY | -3.7 Million USD | -9178.91% |
| 2007 Q2 | -16.98 Thousand USD | 38.05% |
| 2007 Q4 | -3.7 Million USD | 13.77% |
| 2007 Q1 | -27.41 Thousand USD | 0.08% |
| 2007 Q3 | -4.29 Million USD | -25209.69% |
| 2006 Q3 | -28.46 Thousand USD | 0.0% |
| 2006 FY | -39.94 Thousand USD | 0.0% |
| 2006 Q4 | -27.43 Thousand USD | 3.61% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | -655.73 Thousand USD | 17853.801% |
| BIMI International Medical Inc. | 3.11 Million USD | -3632.862% |
| China Jo-Jo Drugstores, Inc. | 10.34 Million USD | -1025.26% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 109.08 Million USD | -6.719% |
| Leafly Holdings, Inc. | 13.79 Million USD | -744.091% |
| Leafly Holdings, Inc. | 13.79 Million USD | -744.091% |
| LifeMD, Inc. | -14.21 Million USD | 919.009% |
| LifeMD, Inc. | -14.21 Million USD | 919.009% |
| TRxADE HEALTH, Inc. | 6.95 Million USD | -1574.582% |
| PetMed Express, Inc. | -53.84 Million USD | 316.22% |
| Walgreens Boots Alliance, Inc. | 8.23 Billion USD | 98.586% |